IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

CUSIP: 46333XAH1

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Debt / NOTE 1.500% 6/1
Market price (% of par)
88.89%
Total 13F principal
$165,440,927
Principal change
$0
Total reported market value
$177,805,855
Number of holders
13
Value change
-$118,626
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 46333XAH1?
CUSIP 46333XAH1 identifies 46333XAH1 - IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q1 2025

As of 31 Mar 2025, IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 was held by 13 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $165,440,927 in principal (par value) of the bond. The largest 10 bondholders included BRAIDWELL LP, DeepCurrents Investment Group LLC, Indaba Capital Management, L.P., D. E. Shaw & Co., Inc., HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, ARISTEIA CAPITAL, L.L.C., PenderFund Capital Management Ltd., Wellesley Asset Management, JPMORGAN CHASE & CO, and BARCLAYS PLC. This page lists 13 institutional bondholders reporting positions for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.